Abstract

Large contact surfaces of protein–protein interactions (PPIs) remain to be an ongoing issue in the discovery and design of small molecule modulators. Peptides are intrinsically capable of exploring larger surfaces, stable, and bioavailable, and therefore bear a high therapeutic value in the treatment of various diseases, including cancer, infectious diseases, and neurodegenerative diseases. Given these promising properties, a long way has been covered in the field of targeting PPIs via peptide design strategies. In silico tools have recently become an inevitable approach for the design and optimization of these interfering peptides. Various algorithms have been developed to scrutinize the PPI interfaces. Moreover, different databases and software tools have been created to predict the peptide structures and their interactions with target protein complexes. High-throughput screening of large peptide libraries against PPIs; “hotspot” identification; structure-based and off-structure approaches of peptide design; 3D peptide modeling; peptide optimization strategies like cyclization; and peptide binding energy evaluation are among the capabilities of in silico tools. In the present study, the most recent advances in the field of in silico approaches for the design of interfering peptides against PPIs will be reviewed. The future perspective of the field and its advantages and limitations will also be pinpointed.

Highlights

  • The survival of a cell naturally depends on the connections between its proteins

  • We focus on some computational methods for predicting the properties of the protein–protein interactions (PPIs) that can be valuable in circumventing the limitation of traditional pipelines

  • In silico methods are implanted into every corner of the biological analyses

Read more

Summary

INTRODUCTION

The survival of a cell naturally depends on the connections between its proteins. In a single organism, countless cells are connected to form an interactome. A database of experimentally validated tumor homing peptides containing 744 peptides with information on sequence, target tumor, target cell, peptide receptor, techniques of identification, and providing secondary/tertiary structure, amino acid composition, and physicochemical properties of peptides which derived from their sequences A manually curated database of cell-penetrating peptides containing around 1850 peptide entries and providing predicted tertiary structure of peptides, possessing both modified and natural residues. A manually curated resource of experimentally determined hemolytic and non-hemolytic peptides containing 3000 entries that include ∼2000 unique peptides with information on sequence, name, origin, reported function, property such as chirality, types (linear and cyclic), end modifications as well as providing predicted tertiary structure of each peptide A resource of experimentally verified antiviral peptides targeting over 60 medically important viruses including Influenza, HCV, HSV, RSV, HBV, DENV, SARS, etc.

Endpoint Methods
Chemical Methods
Findings
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call